Contact The Organon Access Program Mon-Fri, 8 AM-8 PM ET, at 1-866-809-9515.

The Organon Co-pay Assistance Program

The Organon Co-pay Assistance Program offers assistance to eligible patients who need help affording their medication.
  • Once enrolled, eligible, privately insured patients may pay as little as $0 per prescription and/or administration of their medication.
  • Co-pay assistance from the Organon Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.
You may be eligible if you:
  • Are a resident of the United States
  • Have private health insurance that provides coverage for your medication
  • Have been prescribed your medication for an FDA-approved indication
  • Meet all other Terms and Conditions of the program

The Organon Co-pay Assistance Program is not valid for patients covered under a government program, as that term is defined in the Terms and Conditions. The Organon Co-pay Assistance Program is not valid for uninsured patients.

You and your health care provider must submit all required information. Please see the enrollment form for details.

Other financial support options

What if I am not eligible for the Organon Co-pay Assistance Program?

You may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Organon Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.

Click on the Medication Below for Information or to Enroll:

BILDYOS

BILDYOS®

(denosumab-nxxp) injection 60 mg/mL
Please read the Medication Guide for BILDYOS and discuss it with your doctor. The Physician Prescribing Information, including the Boxed Warning, also is available.
BILPREVDA

BILPREVDA®

(denosumab-nxxp) injection 120 mg/1.7 mL
Please read the Physician Prescribing Information for BILPREVDA and discuss it with your doctor.
HADLIMA

HADLIMA®

(adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL
Please read the Medication Guide for HADLIMA and discuss it with your doctor. The Instructions for Use and Physician Prescribing Information, including the Boxed Warning, also are available.
ONTRUZANT

ONTRUZANT®

(trastuzumab-dttb) for injection, for intravenous use 21 mg/mL
Please read the Physician Prescribing Information for ONTRUZANT, including the Boxed Warning, and discuss it with your doctor.
RENFLEXIS

RENFLEXIS®

(infliximab-abda) for injection, for intravenous use 100 mg
Please read the Medication Guide for RENFLEXIS and discuss it with your doctor. The Physician Prescribing Information, including the Boxed Warning, also is available.
TOFIDENCE

TOFIDENCE®

(tocilizumab-bavi) injection, for intravenous use
Please read the Medication Guide for TOFIDENCE and discuss it with your doctor. The Physician Prescribing Information, including the Boxed Warning, also is available.